Guangcong Ruan

931 total citations · 2 hit papers
13 papers, 599 citations indexed

About

Guangcong Ruan is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Guangcong Ruan has authored 13 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Infectious Diseases. Recurrent topics in Guangcong Ruan's work include Gut microbiota and health (9 papers), Inflammatory Bowel Disease (6 papers) and Gastrointestinal motility and disorders (4 papers). Guangcong Ruan is often cited by papers focused on Gut microbiota and health (9 papers), Inflammatory Bowel Disease (6 papers) and Gastrointestinal motility and disorders (4 papers). Guangcong Ruan collaborates with scholars based in China. Guangcong Ruan's co-authors include Yanling Wei, Dongfeng Chen, Zhifeng Xiao, Fenghua Xu, Minjia Chen, Yi Cheng, Senhong Ying, Yuting Tian, Linling Lv and Yi Cheng and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Microbiology and Nutrients.

In The Last Decade

Guangcong Ruan

13 papers receiving 593 citations

Hit Papers

The role of Th17 cells in inflammatory bowel disease and ... 2023 2026 2024 2025 2023 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The role of Th17 cells in inflammatory bowel disease and the research progress
    2023 87 citations Lu Chen, Guangcong Ruan et al. Frontiers in Immunology profile →
  2. Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design
    2023 81 citations Yi Cheng, Qihui Zhu et al. Gut Microbes profile →

Peers

Guangcong Ruan
Yaoyao Zhuang China
Ruihuan Xu China
Diana M. Flynn United Kingdom
Xiaoyang Ma China
Senhong Ying China
Ruoting Xu China
Yu–Ming Chang Taiwan
Mathieu Méleine France
Yaoyao Zhuang China
Guangcong Ruan
Citations per year, relative to Guangcong Ruan Guangcong Ruan (= 1×) peers Yaoyao Zhuang

Countries citing papers authored by Guangcong Ruan

Since Specialization
Citations

This map shows the geographic impact of Guangcong Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangcong Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangcong Ruan more than expected).

Fields of papers citing papers by Guangcong Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangcong Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangcong Ruan. The network helps show where Guangcong Ruan may publish in the future.

Co-authorship network of co-authors of Guangcong Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Guangcong Ruan. A scholar is included among the top collaborators of Guangcong Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangcong Ruan. Guangcong Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tian, Yuting, Rong Zhao, Lu Chen, et al.. (2025). Multi-omics assessment of gut microbiota in circadian rhythm disorders: a cross-sectional clinical study. Frontiers in Cellular and Infection Microbiology. 15. 1524987–1524987. 1 indexed citations
2.
Qi, Jing, Guangcong Ruan, Ping Yi, et al.. (2023). Development and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis. Therapeutic Advances in Gastroenterology. 16. 1108353921–1108353921. 6 indexed citations
3.
Li, Siyu, Lu Chen, Zhifeng Xiao, et al.. (2023). The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease. Frontiers in Microbiology. 14. 1188455–1188455. 12 indexed citations
4.
Chen, Lu, et al.. (2023). The role of Th17 cells in inflammatory bowel disease and the research progress. Frontiers in Immunology. 13. 1055914–1055914. 87 indexed citations breakdown →
5.
Cheng, Yi, Qihui Zhu, Chun Wang, et al.. (2023). Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design. Gut Microbes. 15(2). 2284247–2284247. 81 indexed citations breakdown →
6.
Ruan, Guangcong, Minjia Chen, Lu Chen, et al.. (2022). Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway. Nutrients. 14(15). 3041–3041. 34 indexed citations
7.
Liu, Lulu, Jiheng Zhang, Mengqing Zhu, et al.. (2022). Gut microbiota: A new target for T2DM prevention and treatment. Frontiers in Endocrinology. 13. 958218–958218. 100 indexed citations
8.
Chen, Minjia, Guangcong Ruan, Lu Chen, et al.. (2022). Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome. Frontiers in Endocrinology. 13. 817100–817100. 79 indexed citations
9.
10.
Ruan, Guangcong, Jia Liu, Yi Yang, et al.. (2022). PHF3 Technique: A Pyramid Hybrid Feature Fusion Framework for Severity Classification of Ulcerative Colitis Using Endoscopic Images. Bioengineering. 9(11). 632–632. 5 indexed citations
11.
Li, Ning, Hongyan Chen, Yi Cheng, et al.. (2021). Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study. Frontiers in Cellular and Infection Microbiology. 11. 759435–759435. 142 indexed citations
12.
Xu, Fenghua, Yi Cheng, Guangcong Ruan, et al.. (2021). New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis. Therapeutic Advances in Gastroenterology. 14. 1088187445–1088187445. 36 indexed citations
13.
Xiao, Zhifeng, Guangcong Ruan, Yi Cheng, et al.. (2021). RFWD3 Participates in the Occurrence and Development of Colorectal Cancer via E2F1 Transcriptional Regulation of BIRC5. Frontiers in Cell and Developmental Biology. 9. 675356–675356. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaoyao Zhuang Breakdown of academic impact, for papers by Ruihuan Xu Breakdown of academic impact, for papers by Diana M. Flynn Breakdown of academic impact, for papers by Xiaoyang Ma Breakdown of academic impact, for papers by Senhong Ying Breakdown of academic impact, for papers by Ruoting Xu Breakdown of academic impact, for papers by Yu–Ming Chang Breakdown of academic impact, for papers by Mathieu Méleine
Rankless by CCL
2026